Skip to Content

Pfizer "Disappointed" with First Results for Alzheimer’s Drug Candidate

Amyloid-recognizing drug has no effect in patients with a high-risk genetic background.

On Monday, Pfizer announced the first of four expected sets of results for its Alzheimer’s drug bapineuzumab. As Steven Romano, head of the company’s Medicines Development Group said in a release, Pfizer is “disappointed”: the drug had no effect on the cognition or day-to-day functioning of patients with the largest known genetic risk for the late-stage onset form of the disease (ApoE4 carriers).

Bapineuzumab is an antibody—a protein that selectively grabs onto a specific protein—that recognizes beta-amyloid, the protein that forms tell-tale plaques in Alzheimer’s patient’s brains (see “Brain Scan for Alzheimer’s”). Because they riddle the brains of patients with the disease, amyloid plaques are one of the major suspects in the enigmatic disease. However, whether these plaques are an instigator of Alzheimer’s or a byproduct of the disease is still a major question for the field.

The company will continue with its trials in patients who do not carry the ApoE4 genetic variant. Results are expected later this summer.

Keep Reading

Most Popular

mouse engineered to grow human hair
mouse engineered to grow human hair

Going bald? Lab-grown hair cells could be on the way

These biotech companies are reprogramming cells to treat baldness, but it’s still early days.

ai learning to multitask concept
ai learning to multitask concept

Meta’s new learning algorithm can teach AI to multi-task

The single technique for teaching neural networks multiple skills is a step towards general-purpose AI.

Death and Jeff Bezos
Death and Jeff Bezos

Meet Altos Labs, Silicon Valley’s latest wild bet on living forever

Funders of a deep-pocketed new "rejuvenation" startup are said to include Jeff Bezos and Yuri Milner.

conceptual illustration showing various women's faces being scanned
conceptual illustration showing various women's faces being scanned

A horrifying new AI app swaps women into porn videos with a click

Deepfake researchers have long feared the day this would arrive.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.